Foxo3a Inhibits Cardiomyocyte Hypertrophy through Transactivating Catalase
Open Access
- 1 October 2008
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (44) , 29730-29739
- https://doi.org/10.1074/jbc.m805514200
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Myosin Regulatory Light Chain Phosphorylation Attenuates Cardiac HypertrophyJournal of Biological Chemistry, 2008
- p53 Initiates Apoptosis by Transcriptionally Targeting the Antiapoptotic Protein ARCMolecular and Cellular Biology, 2008
- Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteinsJournal of Clinical Investigation, 2007
- Requirement of Rac1 in the development of cardiac hypertrophyProceedings of the National Academy of Sciences, 2006
- Glycogen Synthase Kinase 3β Inhibits Myocardin-Dependent Transcription and Hypertrophy Induction Through Site-Specific PhosphorylationCirculation Research, 2005
- Relief from a heavy heart: redox-sensitive NF-κB as a therapeutic target in managing cardiac hypertrophyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Calcium–calcineurin signaling in the regulation of cardiac hypertrophyBiochemical and Biophysical Research Communications, 2004
- Involvement of Nuclear Factor-κB and Apoptosis Signal-Regulating Kinase 1 in G-Protein–Coupled Receptor Agonist–Induced Cardiomyocyte HypertrophyCirculation, 2002
- Reactive Oxygen Species in Mechanical Stress-Induced Cardiac HypertrophyBiochemical and Biophysical Research Communications, 2001
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000